Antibiotic holiday needs to be a long one to combat resistance

January 10, 2011, Yale University

( -- Heavy use of antibiotics has created a host of dangerous drug-resistant pathogens that endanger the health of millions of people. However, it has been unclear how quickly a ban on the overuse of an antibiotic would restore its usefulness.

According to a new study by researchers at Yale University and the University of Tromso in Norway, the "antibiotic holiday" would have to extend over 40 years to be effective.

“Bacterial populations have evolved resistance to most we have,” said Jeffrey Townsend, assistant professor in the Department of Ecology and Evolutionary Biology and co-lead author of the paper, published online Jan. 8 in the Journal of Antimicrobial Chemotherapy. “Since we have failed to develop new antibiotics, many people have proposed that we just need to pause our usage of the ones for which resistance has reached a high frequency. Unfortunately, that alone does not appear to be a viable solution.”

The use of antibiotic avoparcin in farm animals was banned in Europe beginning in 1995 when tests revealed that 75 percent of the bacterium enterococci faecium were resistant to the antibiotic. The antibiotic is a close cousin of vancomycin and teicoplanin, considered drugs of last resort in treating infections. Health officials feared that vancomycin-resistant strains of bacteria might spread to human patients.

The idea behind creating an “antibiotic holiday” is that the bacterium pays a high evolutionary cost to maintain a resistance trait so the dangerous strain of pathogen would eventually disappear in the absence of the antibiotic.

Analyzing the data from Denmark, the researchers found that frequency of the resistant strain of bacteria in farm animals did plummet in the first three years following the ban. However, the resistant strains persisted through 2008 at levels near 2 percent, enough to ensure that a drug-resistant strain would quickly reemerge if the antibiotic were to be reintroduced.

Townsend said a statistical analysis showed it could be as long as 45 years before the frequency of the resistant strain was reduced enough to safely reintroduce the antibiotic. He said that while such antibiotic holidays are still a good idea, their limitations should be recognized.

“Given the decreasing rate of discovery of novel antimicrobial agents, it appears that antibiotic holidays alone have little chance of refurbishing our supply of antimicrobial agents,” Townsend said. “Our only options may be the permanent application of more restricted usage, preventing the evolution of in the first place.”

Related Stories

Recommended for you

DNA gets away: Scientists catch the rogue molecule that can trigger autoimmunity

February 22, 2018
A research team has discovered the process - and filmed the actual moment - that can change the body's response to a dying cell. Importantly, what they call the 'Great Escape' moment may one day prove to be the crucial trigger ...

Low-calorie diet enhances intestinal regeneration after injury

February 22, 2018
Dramatic calorie restriction, diets reduced by 40 percent of a normal calorie total, have long been known to extend health span, the duration of disease-free aging, in animal studies, and even to extend life span in most ...

Artificial intelligence quickly and accurately diagnoses eye diseases and pneumonia

February 22, 2018
Using artificial intelligence and machine learning techniques, researchers at Shiley Eye Institute at UC San Diego Health and University of California San Diego School of Medicine, with colleagues in China, Germany and Texas, ...

Gut microbes protect against sepsis—mouse study

February 22, 2018
Sepsis occurs when the body's response to the spread of bacteria or toxins to the bloodstream damages tissues and organs. The fight against sepsis could get a helping hand from a surprising source: gut bacteria. Researchers ...

Fertility breakthrough: New research could extend egg health with age

February 22, 2018
Women have been told for years that if they don't have children before their mid-30s, they may not be able to. But a new study from Princeton University's Coleen Murphy has identified a drug that extends egg viability in ...

Breakthrough could lead to better drugs to tackle diabetes and obesity

February 22, 2018
Breakthrough research at Monash University has shown how different areas of major diabetes and obesity drug targets can be 'activated', guiding future drug development and better treatment of diseases.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.